Lung Cancer: Are We Up to the Challenge?
Author Information
Author(s): Luca Esposito, Daniele Conti, Ramyasri Ailavajhala, Nansie Khalil, Antonio Giordano
Primary Institution: Sbarro Institute for Cancer Research and Molecular Medicine, Temple University
Hypothesis
The study discusses recent discoveries in lung cancer pathways and the role of genetic and epigenetic factors in diagnosis and targeted therapy.
Conclusion
Lung cancer remains a leading cause of death, and improved early diagnostic tools and targeted therapies are urgently needed.
Supporting Evidence
- Lung cancer is the leading cause of cancer deaths worldwide, with over 1 million deaths annually.
- Non-small cell lung cancer (NSCLC) accounts for about 80% of all lung cancers.
- Recent advances in genetic and biochemical studies have improved understanding of lung cancer.
- Low dose spiral CT detects lung cancer at smaller sizes and earlier than chest X-ray.
Takeaway
Lung cancer is very serious and hard to detect early, but scientists are learning more about it to help find it sooner and treat it better.
Methodology
The review summarizes genetic alterations and discusses potential diagnostic tools and therapeutic strategies for lung cancer.
Limitations
The review does not provide a comprehensive database on lung cancer molecular biology.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website